Chiesi España S.A. - Spain
The growth of the Spanish affiliate reached 5.7%, mainly leveraging on Artedil® (manidipine). This growth rate was affected by a 2.4% price discount that the Spanish Authorities implemented in 2006, in addition to the previous 4.2% discount applied in 2005.

During 2006, the Spanish team mainly worked on preparing Chiesi España for three important corporate product launches planned for 2007. 2006 sales, that exceeded 45 million Euro, should be increased by these launches during the coming years.